Learn how to optimize a Roche Discovery 3-plex assay from staining to image analysis
SUMMARY
In this 60-minute webinar, we will discuss best practices and optimization techniques for Roche Discovery multiplex immunohistochemical (mIHC)assays and HALO® image analysis. First, we will present methods, tips and tricks to design and optimize staining protocols. Next, we will share a series ofmIHC assays wherevarious chromogen combinations were tested on an assay comprised ofthree biomarkers and hematoxylin. From this dataset, we willdiscuss which assays are appropriate for image analysiswith the HALO®Multiplex IHC module, which are not, and why.We will conclude the webinar with a live demo of HALO and HALO AI on a 3-plex assay to quantify staining of a membrane biomarker and to evaluate colocalization of two nuclear biomarkers.
LEARNING OBJECTIVES
Advance your mIHC assay design and optimization knowledge
Improve your brightfield image deconvolution for mIHC analysis with tips and tricks
Learn from examples of successful 3-plex chromogenic image analysis as well as images that are problematic and learn from common challenges
See how HALO AI membrane segmentation and nuclear segmentation can advance your multiplex IHC image analysis in a live demonstration
Kim completed her undergraduate degree in Biochemistry and Cell Biology at the University of California, San Diego, and obtained her PhD from the University of Washington and Fred Hutchinson Cancer Research Center Molecular and Cellular Biology Program where she developed a passion for microscopy. In her postdoctoral fellowship at the Stowers Institute of Medical Research, she continued to use high and super resolution microscopy to advance her research. Kim has 10 years of experience working on product and marketing teams at companies focused on microscopy and image analysis. In her current role, she leads a team of three and manages comarketing partnerships, creation of print and digital scientific and clinical marketing content, and events supporting Indica Labs’ products and services.
Rivers brings more than 20 years of experience commercializing diagnostic and digital pathology technologies to support ViewsML’s continued growth and innovation
Vancouver, BC —September 29, 2026— ViewsML, a leader in AI-powered virtual...